Cited by 104Cannabis and Cannabinoid ResearchEicosanoids and Hypertension PharmacologyFatty Acid Research and Health

Fatty Acid Amide Hydrolase: A Gate-Keeper of the Endocannabinoid System

Fezza, Filomena, De Simone, Chiara, Amadio, Daniele, Maccarrone, Mauro·2008·Subcellular Biochemistry

Abstract

The family of endocannabinoids contains several polyunsaturated fatty acid amides such as anandamide (AEA), but also esters such as 2-arachidonoylglycerol (2-AG). These compounds are the main endogenous agonists of cannabinoid receptors, able to mimic several pharmacological effects of Delta9-tetrahydrocannabinol (Delta9-THC), the active principle of Cannabis sativa preparations like hashish and marijuana. The activity of AEA at its receptors is limited by cellular uptake, through a putative membrane transporter, followed by intracellular degradation by fatty acid amide hydrolase (FAAH). Growing evidence demonstrates that FAAH is the critical regulator of the endogenous levels of AEA, suggesting that it may serve as an attractive therapeutic target for the treatment of human disorders. In particular, FAAH inhibitors may be next generation therapeutics of potential value for the treatment of pathologies of the central nervous system, and of peripheral tissues. Investigations into the structure and function of FAAH, its biological and therapeutic implications, as well as a description of different families of FAAH inhibitors, are the topic of this chapter.

Integrity signals

Registry

Crossref · 10.1007/978-1-4020-8831-5_4

Cites

156 of 156 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • FAAH hydrolyzes PEA, which does not bind cannabinoid receptors but functions as an endogenous ligand for PPAR-α.

    “Besides serving as the major catabolic enzyme of AEA, FAAH hydrolyzes other bioactive lipids, such as N-palmitoylethanolamine (PEA) (Fezza et al, 2008), which does not bind cannabinoid receptors, but functions as an endogenous ligand for peroxisome proliferator receptor-α (PPAR-α) (Lo Verme et al, 2005).”
  • FAAH is the principal catabolic enzyme for fatty-acid amides including anandamide and N-palmitoylethanolamine.

    “Fatty-acid amide hydrolase (FAAH) is the principle catabolic enzyme for fatty-acid amides including AEA and N-palmitoylethanolamine (PEA).25”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Fezza, F., De Simone, C., Amadio, D., & Maccarrone, M.
Affiliations
University of Rome Tor Vergata (IT)
Venue
Subcellular Biochemistry
Published
2008
Volume
49
Pages
101-132
ISSN
0306-0225 (ISSN-L)
OpenAlex
W97923480
Cited by
99
References
156
Citations by year
2026: 2 · 2025: 2 · 2024: 1 · 2023: 1 · 2022: 3 · 2021: 3 · 2020: 5 · 2019: 2 · 2018: 3 · 2017: 5 · 2016: 9 · 2015: 7 · 2014: 8 · 2013: 7 · 2012: 8
FWCI
44.84
Type
book chapter
Language
en
Open access
closed
Locations
  • Sub-cellular biochemistry/Subcellular biochemistry (publishedVersion)
  • PubMed (publishedVersion)
  • Archivio Istituzionale della Ricerca - Università degli Studi dell Aquila (submittedVersion)
Topics
  • Health Sciences › Medicine › Pharmacology › Cannabis and Cannabinoid Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Eicosanoids and Hypertension Pharmacology
  • Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
Keywords
fatty acid amide hydrolase, endocannabinoid system, anandamide, 2-arachidonoylglycerol, FAAH inhibitors, cannabinoid receptors, delta-9-tetrahydrocannabinol, membrane transporters, intracellular degradation, therapeutic target, central nervous system disorders
MeSH terms
Fatty Acid Amide Hydrolases, Amidohydrolases, Animals, Gene Expression Regulation, Humans, Models, Molecular, Receptors, Cannabinoid, Cannabinoid Receptor Modulators, Endocannabinoids

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review